Keyphrases
Outer Membrane Vesicles
100%
Vaccine Development
100%
Glycoengineering
100%
Bacterial Vaccines
28%
Recombinant
14%
Cell Surface
14%
Antibiotics
14%
Uropathogenic Escherichia Coli
14%
Polysaccharide
14%
Bacterial Infection
14%
Phospholipids
14%
Conjugation
14%
Gram-negative Bacteria
14%
Surface Glycans
14%
Neisseria Meningitidis
14%
Outer Membrane
14%
Biogenesis
14%
Lipopolysaccharide
14%
Vaccine Candidate
14%
Vaccine Types
14%
Blebbing
14%
Streptococcus Pneumoniae
14%
Glycoconjugates
14%
Outer Membrane Protein
14%
Novel Vaccines
14%
Animal Models of Infection
14%
Carrier Protein
14%
Manufacturing Process
14%
Capsular Polysaccharide
14%
Immunological Properties
14%
Surface Carbohydrates
14%
Chemical Method
14%
Vaccine Delivery
14%
O25b
14%
Delivery Platform
14%
Glycoconjugate Vaccines
14%
Biosafety
14%
Haemophilus Influenzae Type b
14%
Post-antibiotic Era
14%
O-antigen
14%
Conjugate Vaccine
14%
Batch-to-batch Variability
14%
Periplasmic Binding Protein
14%
Adjuvanticity
14%
Immunology and Microbiology
Outer Membrane
100%
Membrane Vesicle
100%
Serotype
22%
Glycoconjugate
22%
Infectious Agent
11%
Cell Surface
11%
Membrane Transport Protein
11%
Uropathogenic Escherichia Coli
11%
Glycan
11%
Neisseria meningitidis
11%
Biogenesis
11%
Gram-Negative Bacteria
11%
Rabies Vaccine
11%
Haemophilus Influenzae Type B
11%
Conjugate Vaccine
11%
O Antigen
11%
Streptococcus Pneumonia
11%